Women will only have access to three months’ supply of certain hormone replacement therapy (HRT) products in an effort to tackle shortages across the UK.

Health Secretary Sajid Javid has issued Serious Shortage Protocols (SSPs) to limit the dispensing of the products.

It means that Oestrogel, Ovestin cream and Premique Low Dose will be given out in limited supply to each person to “even out” the distribution.

The move is in response to concerns regarding longer prescribing cycles putting pressure on the availability of some HRT products.

However, those who already have a prescription for more than three months’ supply will not be required to pay the additional charges for treatment they cannot access, the Department of Health and Social Care (DHSC) confirmed.

Mr Javid said: “I want to reassure women I have listened to their concerns and will not hesitate to take decisive action to ensure they can access the HRT they need.

“We will leave no stone unturned in our national mission to boost supply of HRT – and this next step will ensure women across the UK will be able to reliably access this vital medication and maintain this lifeline for millions who need it.”

Hormone replacement therapy tsar to be appointed as drug shortages leave women feeling suicidal

Inquiry into gender treatment for children to be launched by Health Secretary Sajid Javid

New law to ban NHS England from using supply chains linked to slavery

Hormone therapy helps to combat menopausal symptoms, which include anxiety, joint pain, disturbed sleep and hot flushes.

The health department said the SSPs will expire on 29 July, with pharmacists expected to “use their professional judgement” in deciding how to apply them.

NHS data suggests that prescriptions for HRT have more than doubled in England over the past five years.

Some 538,000 HRT prescriptions were issued in December, compared with 238,000 in January 2017, figures from OpenPrescribing suggest.

Please use Chrome browser for a more accessible video player

Amidst the ongoing shortages, the firm behind popular HRT treatment Oestrogel recently said it is on track to meet growing demand.

Read more: Hormone replacement therapy tsar to be appointed as drug shortages leave women feeling suicidal

Besins Healthcare UK, which makes the gel, said that from June women will be able to get longer-term prescriptions and more people can start HRT as they plan to increase supplies.

Mr Javid announced on Thursday that he had appointed Madelaine McTernan, director-general of the COVID Vaccine Taskforce, to lead a new HRT taskforce, which the government said “will apply lessons it has learned from rolling out the coronavirus vaccine”.

Ms McTernan said: “This is a step in the right direction of tackling the supply issues women are facing when it comes to accessing HRT and ensuring ongoing, reliable supply.”

Related posts:

Hancock insists 1% salary increase for NHS staff is ‘pay rise’ – despite 1.5% inflation Home Secretary considering sending asylum seekers thousands of miles away to be processed ‘Hard to see’ how Northern Ireland Protocol can remain sustainable, Brexit minister tells MPs Travel firm TUI joins airlines suing government over ‘inexplicable’ amber list rules PMQs: Johnson apologises to businesses over ‘pingdemic’ after more than half a million told to isolate ‘We can’t blow it now’: COVID cases could hit 100,000 a day – but England won’t move to Plan B yet Booster jab rules will not change unless JCVI says so, minister says Patel blames rise in migrant crossings on EU having ‘no border protections whatsoever’ Ex-Tory MP jailed for sexual assault now claiming benefit as he tells court he can’t pay costs ‘Stuck in the dark ages’: Sajid Javid says sports bodies are failing to tackle racism Why the government’s social care cap plan is worrying some Tory MPs Rebel Tory ‘was going to withdraw no-confidence letter until PM said Ukraine fight was like Brexit’